Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2

被引:23
|
作者
Agamennone, M
Campestre, C
Preziuso, S
Consalvi, V
Crucianelli, M
Mazza, F
Politi, V
Ragno, R
Tortorella, P
Gallina, C
机构
[1] Univ G dAnnunzio, Dipartimento Sci Farmaco, I-66013 Chieti, Italy
[2] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy
[3] Univ Aquila, Dipartimento Chim Ingn Chim & Mat, I-67010 Coppito, Italy
[4] Polifarma Res Ctr, I-00185 Rome, Italy
[5] Univ Bari, Dipartimento Farmacochim, I-70125 Bari, Italy
关键词
MMP; matrix metalloproteinases inhibitors; tripeptide phosphonates; right-hand inhibitors; left-hand inhibitors;
D O I
10.1016/j.ejmech.2004.10.013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The phosphotryptophan derivative L-Pro-L-LeU-L-(P)Trp(OH)(2) (2b) was reported as the first example of left-hand-side(1) phosphonate inhibitor of MMP-8. Its uncommon mode of binding to MMP-8 was mainly ascribed to the presence of the proline residue in P, Ten new analogues of 2b were obtained by replacement of the aminoterminal L-Pro with aminoacid residues bearing small side chains. Most of the new analogues show an increase of affinity for MMP-2 and MMP-8, and different profiles of selectivity. Computer simulations were performed to explain the effects of substitutions on the preferred mode of binding. They reveal that most of the new analogues are probably accommodated in the right. rather than left-hand side of MMP-8 active site. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 50 条
  • [1] Design, modelling, synthesis and biological evaluation of peptidomimetic phosphinates as inhibitors of matrix metalloproteinases MMP-2 and MMP-8
    Bianchini, G
    Aschi, M
    Cavicchio, G
    Crucianelli, M
    Preziuso, S
    Gallina, C
    Nastari, A
    Gavuzzo, E
    Mazza, F
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (15) : 4740 - 4749
  • [2] Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy
    Wang, Zhong-Chang
    Shen, Fa-Qian
    Yang, Meng-Ru
    You, Ling-Xia
    Chen, Li-Zhi
    Zhu, Hai-Liang
    Lu, Ya-Dong
    Kong, Fan-Lei
    Wang, Ming-Hua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (23-24) : 3816 - 3821
  • [3] Influence of TEGDMA monomer on MMP-2, MMP-8, and MMP-9 production and collagenase activity in pulp cells
    Bálint Viktor Lovász
    Edina Lempel
    József Szalma
    György Sétáló
    Mónika Vecsernyés
    Gergely Berta
    Clinical Oral Investigations, 2021, 25 : 2269 - 2279
  • [4] Influence of TEGDMA monomer on MMP-2, MMP-8, and MMP-9 production and collagenase activity in pulp cells
    Lovasz, Balint Viktor
    Lempel, Edina
    Szalma, Jozsef
    Setalo, Gyorgy, Jr.
    Vecsernyes, Monika
    Berta, Gergely
    CLINICAL ORAL INVESTIGATIONS, 2021, 25 (04) : 2269 - 2279
  • [5] MMP-8: a new target for atherosclerosis?
    Fricker, J
    DRUG DISCOVERY TODAY, 2002, 7 (02) : 86 - 88
  • [6] Design, Synthesis, and Evaluation of Kirenol Derivatives as MMP-8 Inhibitors with Anti-inflammatory Activity
    Zhao, Ting-Ting
    Liu, Lei
    Wu, Ying-Li
    Sun, Kang-Ping
    Sun, Jing-Yong
    CHEMISTRYSELECT, 2023, 8 (19):
  • [7] Macrocyclic amino carboxylates as selective MMP-8 inhibitors
    Cherney, RJ
    Wang, L
    Meyer, DT
    Xue, CB
    Wasserman, ZR
    Hardman, KD
    Welch, PK
    Covington, MB
    Copeland, RA
    Arner, EC
    DeGrado, WF
    Decicco, CP
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) : 1749 - 1751
  • [8] Design, Synthesis and Biological Evaluation of Caffeic Acid Amides as Selective MMP-2 and MMP-9 Inhibitors
    Shi, Zhi-Hao
    Li, Nian-Guang
    Shi, Qian-Ping
    Tang, Hao
    Tang, Yu-Ping
    Li, Wei
    Yin, Lian
    Yang, Jian-Ping
    Duan, Jin-Ao
    DRUG DEVELOPMENT RESEARCH, 2012, 73 (06) : 343 - 351
  • [9] hCG对绒癌细胞系MMP-2和MMP-8表达的影响
    庞战军
    邢福祺
    周君桂
    生命科学研究, 2002, (02) : 175 - 178
  • [10] MMP-8 and active MMP-8 (aMMP-8) are not synonymous in periodontal disease diagnostics
    Sahni, Vaibhav
    Raisanen, Ismo Tapani
    Sorsa, Timo
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2024, 51 (03) : 365 - 365